Skip to main content
. Author manuscript; available in PMC: 2022 Jun 17.
Published in final edited form as: Exp Eye Res. 2020 Nov 16;202:108361. doi: 10.1016/j.exer.2020.108361

Fig. 7.

Fig. 7.

Application of specific genes (HGF, BPM7, decorin, VEGF-A, Smad7) delivered to the corneal stroma attenuates conditions such as corneal fibrosis, neovascularization and fibroblast differentiation to myofibroblasts.